Get E&O weekly. | Subscribe
Digital health research from Brian Dolan.
Welcome to E&O.
Last Friday I wrote about ICER's blistering report on Pear, Orexo's DTC move with its substance use disorder DTx, plus feedback for CMS on its plans for reimbursing breakthrough devices.
And if you